Adverum Biotechnologies Inc’s recent filing unveils that its 10% Owner Leonard Braden Michael acquired Company’s shares for reported $0.1 million on Mar 26 ’25. In the deal valued at $5.04 per share,20,407 shares were bought. As a result of this transaction, Leonard Braden Michael now holds 125,207 shares worth roughly $0.4 million.
Then, Leonard Braden Michael bought 16,593 shares, generating $86,089 in total proceeds. Upon buying the shares at $5.19, the 10% Owner now owns 141,800 shares.
Before that, Leonard Braden Michael bought 300,000 shares. Adverum Biotechnologies Inc shares valued at $900,000 were divested by the 10% Owner at a price of $3.00 per share. As a result of the transaction, Leonard Braden Michael now holds 3,057,526 shares, worth roughly $9.88 million.
Oppenheimer initiated its Adverum Biotechnologies Inc [ADVM] rating to an Outperform in a research note published on June 25, 2024; the price target was $25. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late April with a ‘”a Buy”‘ rating. Truist also remained covering ADVM and has increased its forecast on July 07, 2022 with a “Buy” recommendation from previously “Hold” rating. Cantor Fitzgerald revised its rating on July 23, 2021. It rated ADVM as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of ADVM
On Tuesday, Adverum Biotechnologies Inc [NASDAQ:ADVM] saw its stock fall -10.03% to $3.23. Adverum Biotechnologies Inc shares have fallen nearly -30.84% since the year began. Nevertheless, the stocks have fallen -67.70% over the past one year. While a 52-week high of $10.84 was reached on 03/21/25, a 52-week low of $2.64 was recorded on 04/28/25. SMA at 50 days reached $4.01, while 200 days put it at $5.74.
Levels Of Support And Resistance For ADVM Stock
The 24-hour chart illustrates a support level at 3.07, which if violated will result in even more drops to 2.92. On the upside, there is a resistance level at 3.48. A further resistance level may holdings at 3.74. The Relative Strength Index (RSI) on the 14-day chart is 44.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.00%. Stochastics %K at 75.74% indicates the stock is a holding.
